Hansoh Pharmaceutical Group Co Ltd 03692
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- HK$35.30
- Day Range
- HK$33.64–34.66
- 52-Week Range
- HK$28.06–44.22
- Bid/Ask
- HK$34.14 / HK$34.16
- Shares Outstanding
- 6.06B
- Market Cap
- HK$206.98B
- Volume/Avg
- 16M / 12M
Key Statistics
- Price/Earnings (Normalized)
- 27.93
- Price/Sales
- 11.68
- Dividend Yield (Trailing)
- 1.42%
- Dividend Yield (Forward)
- 1.42%
- Dividend Payment Schedule
- Jul, Oct
- Total Yield
- 1.42%
Company Profile
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 9,347
- Website
- https://www.hspharm.com
Valuation
|
Metric
|
03692
|
|---|---|
Price/Earnings (Normalized) | 27.93 |
Price/Book Value | 4.78 |
Price/Sales | 11.68 |
Price/Cash Flow | 32.79 |
Price/Earnings
03692
Financial Strength
|
Metric
|
03692
|
|---|---|
Quick Ratio | 4.80 |
Current Ratio | 4.88 |
Interest Coverage | 135.50 |
Quick Ratio
03692
Profitability
|
Metric
|
03692
|
|---|---|
Return on Assets (Normalized) | 16.52% |
Return on Equity (Normalized) | 19.41% |
Return on Invested Capital (Normalized) | 15.96% |
Return on Assets
03692
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|XgK%<<^$ | LOCK|?#s! | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|Jll&nF# | LOCK|g<K%k | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|!q^>Ys$ | LOCK|f> | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|FWm<Llx | LOCK|!?h | $29B | |||
| Viatris Inc
VTRS
| LOCK|skgt!B | LOCK|%Mb | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|rJQ | LOCK|?K$ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|fN>&jl | LOCK|&vS | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|w>&$b!y | LOCK|?n | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|?k@<Sxv | LOCK|XHd< | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|HwdjKW | LOCK|BYz | $2B |
United States